It's a tough gig out there in share land.
The announcement, however, doesn't disappoint - its right on the money and accords with the media pre-release and sharesontoast discussion with Paul Watt. Phylogica published a table, in its March 2010 presentation, setting out the payment structure for Discovery Pharma Partnerships;
Upfront license fee - $500k
Milestone payments - $1m-$100m
The licensing agreement with Medlmmune has delivered, in fact its more than a Pass mark, its a High Distinction. The market gives it a big yawn but the Big Pharma players keep lining up for a slice of the action.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.39 |
Change
0.030(2.21%) |
Mkt cap ! $810.7M | |||
| Open | High | Low | Value | Volume |
| $1.39 | $1.39 | $1.33 | $103.4K | 75.90K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2600 | $1.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.39 | 14999 | 1 |
View Market Depth
| Last trade - 16.10pm 21/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |